MedTrace Logo

Inspiratory Muscle Training in Children and Adolescents With Idiopathic Scoliosis Undergoing Schroth Therapy.

NCT07177430 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 56

Last updated 2025-12-05

No results posted yet for this study

Summary

This study evaluates the effectiveness of inspiratory muscle training in children and adolescents with idiopathic scoliosis undergoing therapy with the Schroth method.

The intervention- inspiratory muscle training- aims to improve respiratory function, increase exercise tolerance, and strengthen core stability in the participants.

The proposed training may enhance the effectiveness of therapy conducted using the Schroth method and improve participants' performance in activities of daily living.

The project aims to assess the impact of inspiratory muscle training in children and adolescents with idiopathic scoliosis on respiratory system function, exercise tolerance, and core stability.

Conditions

  • Scoliosis Idiopathic

Interventions

DEVICE

Inspiratory Muscle Training

Participants will perform inspiratory muscle training using a respiratory muscle trainer. The initial training load will be set at 30% of PImax. The intervention will last for 8 weeks and will be carried out 5 days per week, twice daily, in 3 sets of 10 repetitions. The training load will be increased in the 2nd, 4th, and 6th week of the program, each time by an additional 10% relative to the initial PImax.

DEVICE

Inspiratory Muscle Training (Sham)

The training intervention in the Sham Group will differ from the experimental group only in terms of training load. This load will remain constant at 15% PImax, which does not cause any changes in the functioning of the inspiratory muscles. All other training parameters will be identical to those in the IMT group.

Sponsors & Collaborators

  • Wroclaw University of Health and Sport Sciences

    lead OTHER

Principal Investigators

  • Krystyna Rożek-Piechura, Professor · Wroclaw University of Health and Sport Sciences, Poland

  • Aleksandra Grudzińska, MSc · Wroclaw University of Health and Sport Sciences, Poland

  • Elżbieta Piątek-Krzywicka, PhD · Wroclaw University of Health and Sport Sciences, Poland

  • Anna Badowska, MD

  • Jerzy R Piechura, PhD · Wroclaw University of Health and Sport Sciences, Poland

  • Paulina Okrzymowska, PhD · Wroclaw University of Health and Sport Sciences, Poland

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
11 Years
Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-10-13
Primary Completion
2027-05-31
Completion
2027-07-31

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07177430 on ClinicalTrials.gov